These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 18705442)
1. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre. Pagalavan L; Ong SG Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442 [TBL] [Abstract][Full Text] [Related]
2. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Poormoghim H; Lucas M; Fertig N; Medsger TA Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887 [TBL] [Abstract][Full Text] [Related]
4. Juvenile systemic sclerosis: a follow-up study of eight patients. Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963 [TBL] [Abstract][Full Text] [Related]
6. [Anti-Scl-70 antibodies in systemic scleroderma]. Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650 [TBL] [Abstract][Full Text] [Related]
7. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581 [TBL] [Abstract][Full Text] [Related]
8. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease]. Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782 [TBL] [Abstract][Full Text] [Related]
9. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J; Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608 [TBL] [Abstract][Full Text] [Related]
10. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies. Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499 [TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F; Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611 [TBL] [Abstract][Full Text] [Related]
13. A study of the prevalence of systemic sclerosis in northeast England. Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101 [TBL] [Abstract][Full Text] [Related]
14. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. Negi VS; Tripathy NK; Misra R; Nityanand S J Rheumatol; 1998 Mar; 25(3):462-6. PubMed ID: 9517764 [TBL] [Abstract][Full Text] [Related]
15. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis. Fritzler MJ; Hart DA; Wilson D; García-De La Torre I; Salazar-Páramo M; Vázquez-Del Mercado M; Senécal JL; Loyau S; Anglés-Cano E J Rheumatol; 1995 Sep; 22(9):1688-93. PubMed ID: 8523346 [TBL] [Abstract][Full Text] [Related]
17. [Clinical study on two cases of progressive systemic sclerosis with anti Wa antibody]. Mita S; Adachi M; Tomii M; Matsuoka Y; Irimajiri S; Miyachi K; Takano S; Matsushima H; Hiwatashi T Ryumachi; 1989 Oct; 29(5):365-70. PubMed ID: 2634885 [TBL] [Abstract][Full Text] [Related]
18. Juvenile systemic sclerosis: report of three cases and review of Japanese published work. Aoyama K; Nagai Y; Endo Y; Ishikawa O J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371 [TBL] [Abstract][Full Text] [Related]
19. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody]. Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510 [TBL] [Abstract][Full Text] [Related]
20. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Nihtyanova SI; Brough GM; Black CM; Denton CP Ann Rheum Dis; 2008 Jan; 67(1):120-3. PubMed ID: 17660220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]